about
Comparison Between Botulinum Toxin A Injection and Lacrimal Punctal Plugs for the Control of Post-LASIK Dry Eye Manifestations: A Prospective Study.Prospective analysis of neutralising antibody titres in secondary non-responders under continuous treatment with a botulinumtoxin type A preparation free of complexing proteins--a single cohort 4-year follow-up study.Proteases as therapeutics.Targeted secretion inhibitors-innovative protein therapeuticsBotulinum neurotoxin: where are we with detection technologies?Whole-genome single-nucleotide-polymorphism analysis for discrimination of Clostridium botulinum group I strains.Aminopeptidase secreted by Chromobacterium sp. Panama inhibits dengue virus infection by degrading the E protein.
P2860
Q33740130-118C50BC-733C-4A67-977C-0F5E2A424AFDQ36254051-6C01E696-731B-484D-AD06-6980FF53B941Q37853216-349491F7-07AF-4FD8-9EA0-53565F8B94C4Q37954277-AB60BB09-A117-44EE-AC27-00A7D5195A44Q38016960-67BF4A50-0A0E-460E-BF73-8C681FD98041Q38847706-806496C3-AD5A-4BA1-90B6-EB9A44DD96B5Q55209557-85CB0AAD-37B8-4AC6-85EB-87F3736CCADD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Botulinum toxin drugs: future developments.
@en
Botulinum toxin drugs: future developments.
@nl
type
label
Botulinum toxin drugs: future developments.
@en
Botulinum toxin drugs: future developments.
@nl
prefLabel
Botulinum toxin drugs: future developments.
@en
Botulinum toxin drugs: future developments.
@nl
P1476
Botulinum toxin drugs: future developments.
@en
P2093
D Dressler
P2888
P304
P356
10.1007/S00702-007-0863-9
P577
2008-03-28T00:00:00Z